Predictors of 6‐Month Mortality in Elderly Patients with Mild Chronic Obstructive Pulmonary Disease Discharged from a Medical Ward After Acute Nonacidotic Exacerbation

OBJECTIVES: To identify clinical outcomes and variables associated with 6‐month mortality in very elderly patients admitted for nonacidotic acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

[1]  J. Maurer Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone-Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2008 .

[2]  Y. Fukuchi,et al.  CARBOCISTEINE IMPROVES QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2007, Journal of the American Geriatrics Society.

[3]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[4]  J. Bourbeau,et al.  Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease , 2007, Annals of Internal Medicine.

[5]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[6]  A. Gruneir,et al.  Association Between Advance Directives and Quality of End‐of‐Life Care: A National Study , 2007, Journal of the American Geriatrics Society.

[7]  D. O’Donnell,et al.  COPD exacerbations · 3: Pathophysiology , 2006, Thorax.

[8]  C. D. Mathers,et al.  Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.

[9]  Claire O'Tuathail,et al.  Assessment of older people , 2006 .

[10]  T. Lim,et al.  In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. , 2005, Chest.

[11]  A. Yohannes,et al.  Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. , 2005, Age and ageing.

[12]  G. Frisoni,et al.  Relationship between functional loss before hospital admission and mortality in elderly persons with medical illness. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[14]  W. MacNee Guidelines for chronic obstructive pulmonary disease , 2004, BMJ : British Medical Journal.

[15]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[16]  T. Seemungal,et al.  Longitudinal changes in the nature, severity and frequency of COPD exacerbations , 2003, European Respiratory Journal.

[17]  Emiel F M Wouters,et al.  Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. , 2003, Chest.

[18]  Ramon Gisbert,et al.  Costs of chronic bronchitis and COPD: a 1-year follow-up study. , 2003, Chest.

[19]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[20]  M. Trabucchi,et al.  Prediction of 6-month mortality among older hospitalized adults. , 2001, JAMA.

[21]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[22]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[23]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[24]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[25]  B. Fleury,et al.  The cost of treating COPD patients with long-term oxygen therapy in a French population. , 1996, Chest.

[26]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[27]  W. Knaus,et al.  Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. , 1996, JAMA.

[28]  M. Trabucchi,et al.  FUNCTIONAL AND BIOMEDICAL COMPONENTS IN THE MEASURES OF DISEASE SEVERITY IN OLDER PEOPLE , 1995, Journal of the American Geriatrics Society.

[29]  R. Pistelli,et al.  Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[30]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[31]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[32]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[33]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[34]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[35]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[36]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .